These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M; Cullen MT; Casadei G Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031 [TBL] [Abstract][Full Text] [Related]
23. [Interatrial aneurysm as a cause of supraventricular arrhythmia in a newborn infant]. Calderón Colmenero J; Rijlaarsdam M; Miranda Chávez I; Iturralde P Arch Inst Cardiol Mex; 1995; 65(2):143-7. PubMed ID: 7543743 [TBL] [Abstract][Full Text] [Related]
24. Interatrial conduction defects associated with supraventricular tachycardia in individuals without organic heart disease. WALTERS MB; GRISHMAN A J Mt Sinai Hosp N Y; 1954; 21(1):26-8. PubMed ID: 13163659 [No Abstract] [Full Text] [Related]
25. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia]. Chachua T; Abuladze G; Nebieridze M Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270 [TBL] [Abstract][Full Text] [Related]
26. Adenosine and the treatment of supraventricular tachycardia. Rankin AC; Brooks R; Ruskin JN; McGovern BA Am J Med; 1992 Jun; 92(6):655-64. PubMed ID: 1605147 [TBL] [Abstract][Full Text] [Related]
30. [Management of arrhythmias: current trends]. Schoenfeld P Rev Med Brux; 1996 Oct; 17(5):331-6. PubMed ID: 8992546 [No Abstract] [Full Text] [Related]
31. Independent prognostic value of supraventricular arrhythmias on 24-h ambulatory monitoring following myocardial infarction. de Cock CC; Visser FC; van Eenige MJ; Roos JP Eur Heart J; 1991 Oct; 12(10):1070-5. PubMed ID: 1782931 [TBL] [Abstract][Full Text] [Related]
32. Hemodynamic studies in two cases of Wolff-Parkinson-White syndrome with paroxysmal AV nodal tachycardia. FERRER MI; HARVEY RM Am J Med; 1949 Jun; 6(6):725-33. PubMed ID: 18127659 [No Abstract] [Full Text] [Related]
33. [Plasma electrolytes in patients with paroxysmal supraventricular arrhythmia]. Poleszak K Wiad Lek; 1993 Aug; 46(15-16):561-7. PubMed ID: 7975578 [TBL] [Abstract][Full Text] [Related]
34. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion]. Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799 [TBL] [Abstract][Full Text] [Related]
35. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Pritchett EL; McCarthy EA; Wilkinson WE Ann Intern Med; 1991 Apr; 114(7):539-44. PubMed ID: 2001087 [TBL] [Abstract][Full Text] [Related]
36. [The place of the electrophysiology examination and radiofrequent ablation in cardiac arrhythmias]. Nurkić M; Mujanović E; Terzić I Med Arh; 2007; 61(2 Suppl 1):44-7. PubMed ID: 21553444 [TBL] [Abstract][Full Text] [Related]
37. Clinical value of transesophageal atrial stimulation and recording in patients with arrhythmia-related symptoms or documented supraventricular tachycardia--correlation to clinical history and invasive studies. Pehrson SM; Blomström-Lundqvist C; Ljungström E; Blomström P Clin Cardiol; 1994 Oct; 17(10):528-34. PubMed ID: 8001299 [TBL] [Abstract][Full Text] [Related]